Bilirubin Oxidase Market Report 2026

The bilirubin oxidase market size has grown strongly in recent years. It will grow from $1.69 billion in 2025 to $1.85 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing prevalence of liver disorders, growing neonatal jaundice cases, rising demand for enzyme-based diagnostics, expansion of clinical testing infrastructure, and increasing awareness of liver health.

The bilirubin oxidase market size is expected to see strong growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to rising adoption of point-of-care testing, growing investment in biotechnology, increasing use of bilirubin oxidase in research applications, expansion of newborn screening programs,and rising healthcare expenditure in emerging markets. Major trends in the forecast period include advancement in enzyme technology, innovation in biosensors and diagnostic devices, development of recombinant enzyme variants, research and development in bioelectronic applications, and integration of bilirubin oxidase in clinical diagnostics.

The rising incidence of liver diseases is anticipated to fuel the expansion of the bilirubin oxidase market in the coming years. Liver diseases include a wide array of medical conditions that compromise the liver's vital functions, such as detoxification, protein synthesis, and bile production. These conditions can be acute or chronic and may result from factors such as viral infections (e.g., hepatitis), alcohol consumption, fatty liver buildup, autoimmune reactions, genetic abnormalities, or exposure to toxins. The prevalence of liver disorders is increasing due to unhealthy dietary patterns, including high intake of fatty foods and sugary beverages, which can gradually damage the liver. Bilirubin oxidase aids in addressing the growing incidence of liver diseases by facilitating precise measurement of bilirubin levels, supporting early diagnosis and monitoring of liver function. For example, in December 2024, according to the Official Statistics, a UK government agency, premature deaths due to alcoholic liver disease increased by 3.6% in 2023, reaching 5,984 compared to 5,776 in 2022. Consequently, the rising prevalence of liver diseases is driving the growth of the bilirubin oxidase market.

Major companies in the bilirubin oxidase field are emphasizing technological innovations, including microorganism-derived bilirubin oxidase, to address the growing need for more efficient and environmentally friendly treatments for jaundice and bilirubin-related conditions. Microorganism-derived bilirubin oxidase provides a biocatalytic approach that surpasses conventional chemical methods, delivering a safer and more natural means of bilirubin degradation. For example, in December 2023, Creative Enzymes, a biotechnology company based in the US, introduced a new Microorganism-Derived Bilirubin Oxidase, an enzyme specifically developed to improve bilirubin breakdown in medical applications. This enzyme is produced using genetically engineered microorganisms and demonstrates higher efficiency in degrading bilirubin than traditional chemical techniques. Its highly purified composition ensures enhanced stability and improved performance in clinical environments. The enzyme is expected to have wide-ranging applications in the treatment of neonatal jaundice and other bilirubin-related disorders, potentially reducing the reliance on invasive procedures such as blood transfusions.

In December 2023, Calmark Sweden AB, an Israel‑based provider of medical diagnostic biotechnology solutions, including bilirubin tests, formed a partnership with Techno Orbits to enhance neonatal bilirubin testing in Saudi Arabia. Through this collaboration, Calmark aimed to support market entry and obtain regulatory approval for its neonatal bilirubin test in Saudi Arabia by utilizing Techno Orbits’ established distribution network and healthcare connections, including relationships with the Ministry of Health. Techno Orbits, a Saudi Arabia‑based distributor of medical devices and diagnostic solutions, is responsible for overseeing regional distribution and sales of Calmark’s bilirubin testing products.

Major companies operating in the bilirubin oxidase market are Sigma-Aldrich Co. LLC, MP Biomedicals LLC, Sekisui Diagnostics LLC, Aladdin Reagent Co. Ltd., J & K Scientific Ltd., BuyersGuideChem.com, Bluetiger Scientific, ChemicalBook Inc., SRL Inc., MedChemExpress LLC, MyBioSource Inc., Creative Biogene Inc., Creative Enzymes, Lori Industry Co. Ltd., BioHippo, Anjing Dulai Biotechnology Co. Ltd., ANHUI WITOP BIOTECH CO. LTD., Kalikund Enterprises, Career Henan Chemical Co., Wuhan Fortuna Chemical Co. Ltd.

North America was the largest region in the bilirubin oxidase market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bilirubin oxidase market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bilirubin oxidase market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have influenced the bilirubin oxidase market by affecting the cost and availability of enzymes and raw materials used in biosensor and biofuel cell production. higher import duties on enzyme variants have increased production costs, impacting segments such as high-purity clinical-grade enzymes and recombinant enzymes, particularly in north america and europe. however, tariffs have also encouraged local manufacturing investments and innovation, leading to more cost-efficient and scalable enzyme production methods.

Bilirubin oxidase is an enzymatic protein that facilitates the oxidation of bilirubin to biliverdin, utilizing molecular oxygen as the electron acceptor. It is part of the multicopper oxidase family and is involved in bilirubin degradation, electron-transfer reactions, and bioelectrochemical processes. Bilirubin oxidase finds extensive use in biosensors, biofuel cells, diagnostic assays, and biotechnological applications because of its capacity to operate efficiently under physiological conditions and maintain stable redox reactions.

The main types of bilirubin oxidase include fungal bilirubin oxidase, bacterial bilirubin oxidase, recombinant bilirubin oxidase, and high-purity clinical-grade enzyme. Fungal bilirubin oxidase is widely used because of its strong stability, broad pH tolerance, and suitability for clinical diagnostics, biosensors, and biofuel cell applications, ensuring reliable enzymatic performance for both laboratory and industrial use. The different grades include dominant, research grade, and industrial. Applications include clinical diagnostics, biosensors and bioelectronics, biofuel cells and enzymatic energy systems, pharmaceutical research, enzymatic dye oxidation, and others, and they are used by end users such as diagnostic kit and reagent manufacturers, hospitals and clinical laboratories, biotechnology companies, research institutes and universities, and bioelectronics and sensor technology firms.

The bilirubin oxidase market consists of sales of products such as bilirubin oxidase enzymes, enzyme powders, enzyme solutions, immobilized bilirubin oxidase, biosensor kits containing bilirubin oxidase, diagnostic assay kits, and laboratory reagents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.